Comparative effects of a dipeptidyl peptidase-4 inhibitor and of NPH insulin on peripheral nerve conduction of patients with type 2 diabetes

Benzer Materyaller

• Left ventricular diastolic function in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor- a pilot study
  Yazar:: Nogueira, Katia Camarano, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV
  Yazar:: Bjelke, Jais R., ve diğerleri
  Baskı/Yayın Bilgisi: (2006)
• Selective Fluorescence Probes for Dipeptidyl Peptidase Activity - Fibroblast Activation Protein and Dipeptidyl Peptidase IV
  Yazar:: Lai, Koon Siew, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• The Dipeptidyl-Peptidase-Like Protein DPP6 Determines the Unitary Conductance of Neuronal Kv4.2 Channels
  Yazar:: Kaulin, Yuri A., ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Treatment Discontinuation and Clinical Events in Type 2 Diabetes Patients Treated with Dipeptidyl Peptidase-4 Inhibitors or NPH Insulin as Third-Line Therapy
  Yazar:: Moura, Cristiano S., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)